Skip to main content
. 2021 Sep 22;13(10):1538. doi: 10.3390/pharmaceutics13101538

Figure 1.

Figure 1

Schematic representation of most common actively targeted nanocarriers developed by Italian Technology research groups using ligand-based strategies over the last 10 years.